Atrial Fibrillation (AF) Clinical Trials in Birmingham, Alabama

3 studies are recruiting for atrial fibrillation (af) in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

    Conquer-AF is a prospective, multi-center, interventional, non-randomized clinical study that will enroll up to 400 subjects at up to 30 sites across the United States, Europe, and Australia. Subjects diagnosed with symptomatic recurrent paroxysmal or persistent atrial fibrillation after a single p…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama
    Locations
    30 in total
    Run by
    Medtronic Cardiac Ablation Solutions

    See if you can join NCT07298473 on ClinicalTrials.gov

  2. Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

    To evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Grandview, Birmingham, Alabama
    Locations
    27 in total
    Run by
    Arga Medtech SA

    See if you can join NCT06784466 on ClinicalTrials.gov

  3. Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

    A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.

    Stage
    Phase 3
    Ages
    65 and older
    Site
    Anthos Investigative Site 1040, Birmingham, Alabama
    Locations
    789 in total
    Run by
    Anthos Therapeutics, Inc.

    See if you can join NCT05712200 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.